MY161415A - A homeopathic formulation - Google Patents
A homeopathic formulationInfo
- Publication number
- MY161415A MY161415A MYPI2010005054A MYPI2010005054A MY161415A MY 161415 A MY161415 A MY 161415A MY PI2010005054 A MYPI2010005054 A MY PI2010005054A MY PI2010005054 A MYPI2010005054 A MY PI2010005054A MY 161415 A MY161415 A MY 161415A
- Authority
- MY
- Malaysia
- Prior art keywords
- homeopathic formulation
- homeopathic
- formulations
- formulation
- causticum
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000001632 homeopathic effect Effects 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 241000208296 Datura Species 0.000 abstract 1
- 241000208278 Hyoscyamus Species 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 abstract 1
- 241000208292 Solanaceae Species 0.000 abstract 1
- SNBXCWVOMQIJEH-UHFFFAOYSA-K calcium;potassium;hydroxide;sulfate Chemical compound [OH-].[K+].[Ca+2].[O-]S([O-])(=O)=O SNBXCWVOMQIJEH-UHFFFAOYSA-K 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Hematology (AREA)
- Medical Informatics (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN940MU2008 | 2008-04-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY161415A true MY161415A (en) | 2017-04-14 |
Family
ID=54253313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2010005054A MY161415A (en) | 2008-04-29 | 2009-04-27 | A homeopathic formulation |
Country Status (15)
Country | Link |
---|---|
US (1) | US20110038949A1 (pt) |
EP (1) | EP2296681A4 (pt) |
JP (2) | JP2011518876A (pt) |
KR (1) | KR101321031B1 (pt) |
CN (1) | CN102014939A (pt) |
AU (1) | AU2009241221B2 (pt) |
BR (1) | BRPI0912026A2 (pt) |
CA (1) | CA2722121A1 (pt) |
CH (1) | CH701268B1 (pt) |
EA (1) | EA201001592A1 (pt) |
IL (1) | IL208902A (pt) |
MX (1) | MX339704B (pt) |
MY (1) | MY161415A (pt) |
SG (1) | SG190594A1 (pt) |
WO (1) | WO2009133573A2 (pt) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110056305A (ko) * | 2008-08-29 | 2011-05-26 | 낸시 조세핀 폴리치 | 동종요법성 치료학적 방법 |
KR101811462B1 (ko) * | 2010-01-11 | 2018-01-25 | 피닉스 바이오테크놀러지 인코포레이티드. | 협죽도 추출물을 포함하는 신경질환 치료용 조성물 |
EP2568958A1 (en) * | 2010-05-14 | 2013-03-20 | Deseret Biologicals, Inc. | Formulations of diluted genetic material and methods for making same |
DE112011102412T5 (de) * | 2010-07-21 | 2013-07-04 | Oleg Iliich Epshtein | Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von mit Atemwegserkrankungen bzw. Atemwegsleiden assoziierten Erkrankungen bzw. Leiden |
US10022335B2 (en) | 2011-03-03 | 2018-07-17 | Nancy Josephine Polich | Homeopathic therapeutic method and compositions |
WO2012129519A1 (en) | 2011-03-23 | 2012-09-27 | Deseret Biologicals, Inc. | Formulations of diluted amino acid segments and methods for making same |
KR20140024877A (ko) * | 2011-03-28 | 2014-03-03 | 마리 케이 인코포레이티드 | 식물 추출물을 포함하는 국소 스킨 케어 제형 |
US9545429B1 (en) * | 2011-09-03 | 2017-01-17 | Biolyte Laboratories, Llc | Homeopathic formulations |
EP2591823A1 (en) * | 2011-11-11 | 2013-05-15 | Biologische Heilmittel Heel GmbH | Composition for treating or preventing neurodegenerative disorders |
RU2484839C1 (ru) * | 2012-02-06 | 2013-06-20 | Михаил Михайлович Шашурин | Способ получения экстракта рододендрона золотистого с пониженным содержанием стероидных (сердечных) гликозидов |
US9278116B2 (en) | 2012-03-15 | 2016-03-08 | Princeton Biotechnology Corporation | Compositions and methods for treatment of pain |
US8551535B1 (en) | 2012-08-06 | 2013-10-08 | Sarah McCann | Homeopathic remedies and methods for enhancing weight loss |
US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
WO2015030567A1 (es) * | 2013-08-30 | 2015-03-05 | Zamarripa Blas Juan Alberto | Mejoras a formulación auxiliar para contrarrestar efectos adversos de tratamientos contra el cáncer y de tratamientos contra algunas enfermedades víricas |
KR101540107B1 (ko) * | 2015-02-05 | 2015-07-30 | 주식회사 다림바이오텍 | 반복적 희석 및 진탕을 이용한 경구용 제제의 제조방법 |
US20170290873A1 (en) * | 2016-04-08 | 2017-10-12 | Stellalife | Method Of Using Homeopathic Kit Containing Gel, Rinse And Spray For Management Of Post-Oral Surgical Recovery And Maintenance Of Oral Health |
US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
US10828251B1 (en) | 2017-01-14 | 2020-11-10 | Biolyte Laboratories, Llc | Homeopathic formulations |
US10617634B1 (en) | 2017-03-10 | 2020-04-14 | Biolyte Laboratories, Llc | Topical homeopathic formulations for menstrual cramps |
CA3076963C (en) * | 2017-11-30 | 2022-03-29 | Canopy Growth Corporation | Liquid dosage forms comprising cannabis, methods of making and use |
WO2020072850A1 (en) * | 2018-10-04 | 2020-04-09 | Stellalife, Inc. | Compositions and methods for promoting and maintaining oral health |
EP4069215A4 (en) | 2019-12-06 | 2024-01-17 | Jlabs Beauty LLC | TOPICAL COMPOSITIONS CONTAINING ROSE OIL AND CANNABIDIOL AND METHODS OF PREPARING AND USING THE SAME |
KR102273322B1 (ko) * | 2020-04-29 | 2021-07-06 | 우보한의연구소(주) | 복합 한약재 추출물을 유효성분으로 포함하는 알츠하이머병 예방, 치료, 또는 개선용 조성물 |
RU2746080C1 (ru) * | 2020-07-20 | 2021-04-06 | Сергей Анатольевич Небера | Гомеопатическое средство для купирования тика век |
EP4368172A1 (de) * | 2022-11-11 | 2024-05-15 | Gernot A. Overbeck | Verfahren zur herstellung eines analogen homöopathischen wirkstoffs, vorrichtung zur durchführung des verfahrens und computerprogrammprodukt |
WO2024141931A1 (en) * | 2022-12-28 | 2024-07-04 | O Sigma Cell And Genetic Llc | Plant hydroethanolic extracts |
WO2024141930A1 (en) * | 2022-12-28 | 2024-07-04 | Immune & Genetics Protocols Llc | Plant hydroethanolic extracts and uses thereof |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2073515C1 (ru) * | 1993-01-20 | 1997-02-20 | Игорь Электринович Острейковский | Способ лечения травматического поражения головного мозга |
RU2074714C1 (ru) * | 1993-03-11 | 1997-03-10 | Игорь Электринович Острейковский | Способ лечения пациентов с поражением центральной нервной системы |
US20060088575A1 (en) * | 1994-03-31 | 2006-04-27 | Brewitt Barbara A | Homeopathic preparations of purified growth factors and purified growth hormones and associated carriers |
DE19738903A1 (de) * | 1997-09-05 | 1999-03-11 | Reimar Dr Med Banis | Stoffe |
RU2143275C1 (ru) * | 1999-05-06 | 1999-12-27 | Общество с ограниченной ответственностью "Доктор Н" | Гомеопатическое лекарственное средство для лечения бессонницы и повышенной нервной возбудимости "валериана-плюс мультигран" |
RU2150288C1 (ru) | 1999-10-25 | 2000-06-10 | Небера Сергей Анатольевич | Гомеопатическое средство для лечения спазма аккомодации |
RU2224526C1 (ru) * | 2002-11-04 | 2004-02-27 | Государственное учреждение Научно-исследовательский институт психического здоровья Томского научного центра СО РАМН | Средство для профилактики и лечения боевой психической травмы |
US7229648B2 (en) * | 2003-03-14 | 2007-06-12 | Dreyer Lee R | Homeopathic formulations useful for treating pain and/or inflammation |
US7037532B2 (en) * | 2004-03-03 | 2006-05-02 | Innovation Ventures, Llc | Hangover relief composition |
US20050249763A1 (en) * | 2004-04-19 | 2005-11-10 | L'oreal | Kit for formulating a cosmetic product |
US20060165812A1 (en) * | 2005-01-21 | 2006-07-27 | Amershire Investment Corporation | Method and topical formulation for treating headaches |
US20070275096A1 (en) * | 2006-05-19 | 2007-11-29 | Trp, Inc., A Nevada Corporation | Composition and methodology for the treatment of hearing impairment symptoms |
IES20100493A2 (en) * | 2007-10-10 | 2010-09-15 | Thomas Farrington | A homeopathic complex |
-
2009
- 2009-04-27 CH CH01796/10A patent/CH701268B1/de unknown
- 2009-04-27 WO PCT/IN2009/000253 patent/WO2009133573A2/en active Application Filing
- 2009-04-27 BR BRPI0912026A patent/BRPI0912026A2/pt not_active Application Discontinuation
- 2009-04-27 EA EA201001592A patent/EA201001592A1/ru unknown
- 2009-04-27 CN CN2009801154875A patent/CN102014939A/zh active Pending
- 2009-04-27 JP JP2011506833A patent/JP2011518876A/ja active Pending
- 2009-04-27 US US12/989,113 patent/US20110038949A1/en not_active Abandoned
- 2009-04-27 CA CA2722121A patent/CA2722121A1/en not_active Abandoned
- 2009-04-27 AU AU2009241221A patent/AU2009241221B2/en not_active Ceased
- 2009-04-27 SG SG2013032313A patent/SG190594A1/en unknown
- 2009-04-27 EP EP09738579A patent/EP2296681A4/en not_active Withdrawn
- 2009-04-27 MX MX2010011715A patent/MX339704B/es active IP Right Grant
- 2009-04-27 KR KR1020107026630A patent/KR101321031B1/ko active IP Right Grant
- 2009-04-27 MY MYPI2010005054A patent/MY161415A/en unknown
-
2010
- 2010-10-24 IL IL208902A patent/IL208902A/en active IP Right Grant
-
2013
- 2013-11-14 JP JP2013236328A patent/JP5819909B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2014062106A (ja) | 2014-04-10 |
MX2010011715A (es) | 2010-12-06 |
KR101321031B1 (ko) | 2013-10-23 |
BRPI0912026A2 (pt) | 2015-10-06 |
US20110038949A1 (en) | 2011-02-17 |
EP2296681A2 (en) | 2011-03-23 |
JP5819909B2 (ja) | 2015-11-24 |
AU2009241221A1 (en) | 2009-11-05 |
KR20100137013A (ko) | 2010-12-29 |
EA201001592A1 (ru) | 2011-08-30 |
IL208902A0 (en) | 2011-01-31 |
JP2011518876A (ja) | 2011-06-30 |
CH701268B1 (de) | 2012-06-15 |
CN102014939A (zh) | 2011-04-13 |
EP2296681A4 (en) | 2012-04-18 |
CA2722121A1 (en) | 2009-11-05 |
AU2009241221B2 (en) | 2015-02-05 |
WO2009133573A3 (en) | 2010-05-06 |
MX339704B (es) | 2016-06-06 |
IL208902A (en) | 2015-09-24 |
SG190594A1 (en) | 2013-06-28 |
WO2009133573A2 (en) | 2009-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY161415A (en) | A homeopathic formulation | |
TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
PL2134704T3 (pl) | Związki i kompozycje pełniące rolę modulatorów aktywności GPR119 | |
WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
MX2007009356A (es) | Compuestos y composiciones como moduladores de ppar. | |
MX2012004078A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
AU2007257423A8 (en) | Purine analogs | |
WO2009012176A3 (en) | Methods and compositions for treating brain diseases | |
MX2010004219A (es) | Agentes de enlace de cd19 y usos de los mismos. | |
MX2009007944A (es) | Compuestos y composiciones de purina como inhibidores de quinasa para el tratamiento de enfermedades relacionadas con plasmodium. | |
MX2009006339A (es) | Compuestos y composiciones como inhibidores de actividad de receptor 1 de cannabinoide. | |
EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
WO2011027222A3 (en) | Immunogenic compositions including tlr activity modulators | |
MX2012002654A (es) | Compuestos y composiciones como moduladores de la actividad de tlr. | |
TW200732296A (en) | Novel compounds | |
SG179120A1 (en) | Novel compounds | |
WO2010151799A3 (en) | Compounds for modulating rna binding proteins and uses therefor | |
MX2009010207A (es) | Peptidos de hidrazido como inhibidores de proteasa ns3 de virus de hepatitis c. | |
TW200602330A (en) | Compounds and compositions as PPAR modulators | |
WO2010151797A3 (en) | Compounds for modulating rna binding proteins and uses therefor | |
MX368459B (es) | Nuevas composiciones para prevenir y/o tratar trastornos degenerativos del sistema nervioso central. | |
TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
UA103930C2 (ru) | Соединения и композиция для лечения паразитарных болезней | |
MX2010000098A (es) | Derivados de guanina policiclicos y sus metodos de uso. | |
MX2009009362A (es) | Forma de dosificacion novedosa. |